MKTX vs SER · P/E 13, rev $817.1M vs rev $56.0K
MarketAxess Holdings Inc (MKTX) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
MKTX currently screens at market cap $4.00B and trailing P/E 13.3. SER currently screens at market cap $29.7M.
Not investment advice. Open the MKTX and SER stock pages for the full models.
Not investment advice.